students wearing masks

COVID-19 Testing Sites

Updated: January 19, 2021, 2 p.m. CST

Multiple sites across campus are available this week for Texas A&M students, faculty and staff to get a COVID-19 test. Students should read this FAQ to learn details about what is required of them; faculty and staff should review these instructions.

A&M’s preferred testing sites (listed below) do not require an appointment or insurance and involve a saliva sample. Results are available within 48 to 72 hours. The locations include:

TEXAS A&M REC CENTER, 187 Corrington Drive

  • Tuesday, Jan. 19: 11 a.m. – 7 p.m.
  • Wednesday, Jan. 20: 8 a.m. – 4 p.m.
  • Thursday, Jan. 21: 11 a.m. – 7 p.m.

Enter through the south entrance, near the baseball stadium, and follow signs to the testing location. Parking is available in Lot 104 with any valid A&M permit. A few designated parking spaces are available for non-permit-holders.

RUDDER EXHIBIT HALL, 401 Joe Routt Blvd.

  • Tuesday, Jan. 19: 10 a.m. – 6 p.m.
  • Wednesday, Jan. 20: 7:30 a.m. – 3 p.m.
  • Thursday, Jan. 21: 10 a.m. – 6 p.m.

ZACHRY COMPLEX, 125 Spence St.

  • Tuesday, Jan. 19: 10 a.m. – 4 p.m.

SBISA Testing Tent, 233 Houston St.

  • Wednesday, Jan. 20: 10 a.m. – 4 p.m. 

COMMONS Testing Tent, 725 Mosher Lane  

  • Wednesday, Jan. 20: 10 a.m. – 4 p.m.

The following testing sites require an appointment, which can be made through the Curative Inc. site. Results are given within three to four days. The test involves a mouth swab.

A.P. BEUTEL Testing Tent, 311 Houston St.

  • Tuesday, Jan. 19 through Friday, Jan. 22: 8 a.m. – 12 p.m.

MAROON LINE, 8441 Riverside Pkwy., Bryan

  • Tuesday, Jan. 19 through Friday, Jan. 22: 12 p.m. – 3 p.m.

Outdoors behind CB1; parking is available for any HSC parking permit holder. A few spots for non-permit holders are available during testing.

Anyone who has not yet been contacted by the Operations Center but who has tested positive should remain in self-isolation, monitor symptoms, notify close contacts if appropriate and complete the COVID-19 reporting process.

Anyone who has been in close contact or suspects they have been exposed to a person with COVID-19 should immediately quarantine, monitor symptoms, complete the COVID-19 reporting process and follow instructions given there, including seeking PCR testing.

Following is the three-step process:

Register prior to going. A personalized link has been distributed via primary Texas A&M email address. If you have not received a registration link, please contact your HR liaison or contact the testing team at Do not forward the link as it’s assigned to you.

Complete the health survey. After registering, a second email will provide a link for you to complete the health survey within 48 hours of taking the test. 

Get tested by Jan. 22. Go to one of the locations listed above, or go to your own healthcare provider/testing site of choice.

If you get tested off campus, there’s a fourth step: Upload the medical or lab record with results. Follow directions outlined in your email with the unique link related to mandatory testing.

Note: Texas A&M is aware that the FDA recently sent out a notice regarding the risk of false negative results with the Curative SARS-Cov-2 tests, which are the COVID-19 tests that the university has been using extensively across the System since last year, and one of the COVID-19 tests available on the Bryan-College Station campuses. Texas A&M officials have discussed the FDA’s notice internally and with Curative. At this time, we see no reason to discontinue use of the Curative tests across our campuses.  The FDA’s notice states that a negative result does not exclude the possibility of COVID-19 and should not be used as the sole basis for treatment or patient management decisions. The System and its members have consistently communicated that, even though individuals may receive a negative result, they should not assume and act as though they do not have the virus, since no test is perfect, and their risk of infection does not end after taking a test. The System and its members have encouraged individuals to continue to take preventive measures to protect themselves and others from SARS-CoV-2 and to seek additional testing and treatment from their healthcare provider in the event that they experience symptoms compatible with COVID-19.